Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis

Neurosurgery

Volumn 41, Issue 5, 1997, Pages 1052-1059

  Jallo, George I ^a,b   Friedlander, David R ^a   Kelly, Patrick J ^a   Wisoff, Jeffrey H ^a   Grumet, Martin ^b   Zagzag, David ^a  

^a Microvascular and Molecular Neuro Oncology Laboratory   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Brain tumors; Cyst; Extracellular matrix; Tenascin C

Indexed keywords

TENASCIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BRAIN ARACHNOID CYST; BRAIN CANCER; BRAIN METASTASIS; CHILD; CLINICAL ARTICLE; CRANIOPHARYNGIOMA; CYST FLUID; EPENDYMOMA; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NEUROEPITHELIOMA; NEUROSURGERY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; ASTROCYTOMA; BIOLOGICAL MARKERS; BRAIN DISEASES; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CYSTS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TENASCIN;

EID: 0030657742     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199711000-00007     Document Type: Article

References (54)

1. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14:53-65, 1977.
2. Banda MJ, Herron GS, Murphy J, Werb Z: Regulation of metalloproteinase activity by microvascular endothelial cells, in Rifkin DB, Klagsbrun H (eds): Current Communications in Molecular Biology: Angiogenesis, Mechanisms and Palhobiology. New York, Cold Spring Harbor Laboratory, 1987, pp 101-109.
3. Bourdon MA, Ruoslahti E: Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 108:1149-1155, 1989.
4. Bourdon MA, Wikstrand CJ, Furthmayer H, Matthews TJ, Bigner DD: Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43:2796-2805, 1983.
5. Brodkey JA, Laywell ED, O'Brien TF, Faissner A, Stefansson K, Dorries HU, Schachner M, Steindler DA: Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg 82:106-112, 1995.
6. Bronner-Fraser M: Distribution and function of tenascin during cranial neural crest development in the chick. J Neurosci Res 21:135-147, 1988.
7. Brooks PC, Clark RF, Cheresh DA: Requirement of vascular integrin avβ3 for angiogenesis. Science 264:569-571, 1994.
8. Burger PC, Scheithauer BW: Tumors of the Central Nervous System. Washington, D.C., Armed Forces Institute of Pathology, 1994, third series, fasc X, pp 86, 94.
9. Carter WG: Transformation-dependent alterations in glycoproteins of the extracellular matrix of human fibroblasts. J Biol Chem 257:13805-13815, 1982.
10. Chiquet M, Fambrough DM: Chick myotendinous antigen: Part II-A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol 98:1937-1946, 1984.
11. Criscuolo GR: The genesis of peritumoral vasogenic brain edema and tumor cysts: A hypothetical role for tumor-derived vascular permeability factor. Yale J Biol Med 66:277-314, 1993.
12. Crossin KL, Hoffman S, Tan S-S, Edelman GM: Cytotactin and its proteoglycan ligand mark structural and functional boundaries in somatosensory cortex of the early postnatal mouse. Dev Biol 136:381-392, 1989.
13. D'Amore PA, Thompson RW: Mechanisms of angiogenesis. Annu Rev Physiol 49:453-464, 1987.
14. Daumas-Duport C: Dysembryoplastic neuroepithelial tumours. Brain Pathol 3:283-295, 1993.
15. Erickson HP, Bourdon MA: Tenascin: An extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 5:71-92, 1989.
16. Erickson HP, Inglesias JL: A six armed oligomer isolated from cell surface fibronectin preparations. Nature 311:267-269, 1984.
17. Erickson HP, Lightner VA: Hexabrachion protein (tenascin, cytotactin, brachionectin) in connective tissues, embryonic brain, and tumors, in Miller KR (ed): Advances in Cell Biology. London, JAI Press, 1988, vol 2, pp 55-90.
18. Folkman J: What is the role of endothelial cells in angiogenesis? Lab Invest 51:601-604, 1984.
19. Frankel SA, German WJ: Glioblastoma multiforme: Review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment. J Neurosurg 15:489-503, 1958.
20. Garin-Chesa P, Melamed MR, Rettig WJ: Immunohistochemical analysis of human neuronectin expression in normal, reactive and neoplastic tissue. J Histochem Cytochem 37:1767-1776, 1989.
21. Grumet M, Huffman S, Crossin KL, Edelman GM: Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc Nail Acad Sei USA 82:8075-8079, 1985.
22. Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T: Expression of tenascin in human gliomas: Its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 85:481-187, 1993.
23. Huffman HJ: Supratentorial brain tumors in children, in Youmans Jr. (ed): Neurological Surgery. Philadelphia, W.B. Saunders Co., 1982, ed 2, pp 2702-2732.
24. Ingber DE, Madri JA, Folkman J: A possible mechanism for inhibition of angiogenesis by angiostatic steroids: Induction of capillary basement membrane dissolution. Endocrinology 119:17681775, 1986.
25. Jones FS, Burgeon MP, Huffman S, Crossin KL, Cunningham BA, Edelman GM: A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sei USA 85:21862190, 1988.
26. Kelly PJ, Suddith RL, Hutchinson HT, Werrback H, Haber B: Endothelial growth factor present in tissue cultures of CNS tumors. J Neurosurg 44:342-346, 1976.
27. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3:255-268, 1993.
28. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I: Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: Biologic and pathologic implications. Hum Pathol 22:636-643, 1991.
29. Kruse J, Keilhauer G, Faissner A, Timpl R, Schachner M: The Jl glycoprotein: A novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature 316:146-148, 1985.
30. Laywell ED, Domes U, Bartsch U, Faissner A, Schachner M, Steindler DA: Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc Natl Acad Sei U S A 89:2634-2638, 1992.
31. Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PMcL, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82-86, 1994.
32. Mackie EJ, Tucker RP, Halfter W, Chiquet-Ehrismann R, Epperlein HH: The distribution of tenascin coincides with pathways of neural crest cell migration. Development 102:237-250, 1988.
33. Madri JA, Basson MD: Extracellular matrix-cell interactions: Dynamic modulators of cell, tissue and organism structure and function. Lab Invest 66:519-521, 1992.
34. McComb RD, Bigner DD: Immunolocalization of monoclonal antibody defined extracellular matrix antigens in human brain rumors. J Neurooncol 3:181-186, 1985.
35. McComb RD, Miller KA: Developmental and reactive expression of tenascin (TN) in the human cerebellum. J Neuropathol Exp Neurol 49:344, 1990 (abstr).
36. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sei U S A 83:7297-7301, 1986.
37. Moringlane Jr., Spinas R, Bohlen P: Acidic fibroblast growth factor (aFGF) is present in the fluid of brain tumor pseudocysts. Acta Neurochir (Wein) 107:88-92, 1990.
38. Nicosia RF, Madri J: The microvascular extracellular matrix: Developmental changes during angiogenesis in the aortic ringplasma clot model. Am J Pathol 128:78-90, 1987.
39. Nistér M, Enblad P, Bäckström G, Söderman T, Persson L, Heldin C-H, Westermark B: Platelet-derived growth factor (PDGF) in néoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid. Br J Cancer 69:952-956, 1994.
40. Prisell P, Persson L, Boethius J, Sara V: Somatomedins in tumour cyst fluid, cerebrospinal fluid, and tumour cytosol in patients with glial tumours. Acta Neurochir (Wein) 89:48-52, 1987.
41. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH: Transforming growth factor Type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sei U S A 83:4167-4171, 1986.
42. Soini Y, Paakko P, Nuorva K, Kamel D, Linnala A, Virtanen I, Lehto V-P: Tenascin immunoreactivity in lung tumors. Am J Clin Pathol 100:145-150, 1993.
43. Spring J, Beck K, Chiquet-Ehrismann R: Two contrary functions of tenascin: Dissection of the active sites by recombinant tenascin fragments. Cell 59:325-334, 1989.
44. Sriramarao P, Mendier M, Bourdon MA: Endothelial cell attachment and spreading on human tenascin is mediated by c 2βi ard av33 integrins. J Cell Sei 105:1001-1012, 1993.
45. Strugar JG, Criscuolo GR, Rothbart D, Harrington WN: Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 83:682-689, 1995.
46. Tan S-S, Crossin KL, Hoffman S, Edelman GM: Asymmetric expression in somites of cytotactin and its proteoglycan ligand is correlated with neural crest cell distribution. Proc Natl Acad Sei USA 84:7977-7981, 1987.
47. Tiitta O, Wahlstrom T, Virtanen I, Gould VE: Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Virchows Arch B Cell Pathol 63:283-287, 1993.
48. Tomita T, McLone D, Naidich T: Mural tumors with cysts in the cerebral hemispheres of children. Neurosurgery 19:998-1005, 1986.
49. Vaughan L, Huber S, Chiquet M, Winterhalter KH: A major, six-armed glycoprotein from embryonic cartilage. EMBO J 6:349-353, 1987.
50. Weindel K, Moringlane Jr., Marme D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: The key to angiogenesis? Neurosurgery 35:439-448, 1994.
51. Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A: Effects of irradiation on the release of growth factors from cultured bovine, porcine and human endothelial cells. Cancer Res 49:5066-5072, 1989.
52. Yoshida J, Wakabayashi T, Okamoto S, Kimura S, Washizu K, Kiyosawa K, Mokuno K: Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour. J Neurol Neurosurg Psychiatry 57:1212-1215, 1994.
53. Zagzag D, Friedlander DR, Dosik J, Chikramane S, Chan W, Greco MA, Allen JC, Dorovini-Zis K, Grumet M: Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 56:182-189, 1996.
54. Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, Cohen H, Grumet M, Greco MA: Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 55:907-914, 1995.